News Ningbo Menovo Pharmaceutical Co., Ltd.

Equities

603538

CNE100002Y25

End-of-day quote Shanghai S.E. Other stock markets 18:00:00 2024-04-29 EDT			5-day change	1st Jan Change
13.8 ^CNY	+3.84%		+11.47%	-27.82%

04-29	Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-29	Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Menovo Pharmaceutical Unit Gets Approval to Register Vildagliptin Tablets	04-23	MT
Ningbo Menovo Pharmaceutical Co., Ltd. cancelled the transaction announced on July 20, 2023	04-15	CI
Menovo Pharma's Unit Gets Nod to Market Clopidogrel Hydrogen Sulfate Tablets	03-06	MT
Menovo Pharma Gets Nod to Market Raw Drug Ingredient for Hypertension Into EU Market; Shares Up 3%	03-04	MT
Ningbo Menovo Pharmaceutical Co., Ltd.(XSSC:603538) dropped from S&P Global BMI Index	12-18	CI
Ningbo Menovo Pharma Registers Seizure Drug in China	12-05	MT
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Menovo Pharmaceutical Unit's Rosuvastatin Calcium Passes Drug Regulator's Technical Review	23-10-11	MT
Ningbo Menovo Pharmaceutical Co., Ltd.(XSSC:603538) added to S&P Global BMI Index	23-09-18	CI
Ningbo Menovo Pharma Registers Blood Pressure Drug	23-09-06	MT
Ningbo Menovo Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Ningbo Menovo Pharmaceutical Co., Ltd. announced that it expects to receive CNY 652 million in funding from Ningbo Menovo Holding Group Co., Ltd. and other investors	23-07-19	CI
Ningbo Menovo Pharmaceutical Co., Ltd. announced that it expects to receive CNY 651.999948 million in funding from Ningbo Menovo Holding Group Co., Ltd. and other investors.	23-07-19	CI
Ningbo Menovo Pharmaceutical Co., Ltd. announced that it expects to receive funding from Ningbo Menovo Holding Group Co., Ltd.	23-07-19	CI
Ningbo Menovo Pharmaceutical Co., Ltd. cancelled the transaction announced on August 15, 2022	23-07-19	CI
Menovo Pharmaceutical's Unit Gets Nod to Own Olmesartan Medoxomil Tablets	23-07-14	MT
Menovo Pharma Gets European Certification for Diet Drug	23-06-08	MT
Menovo Pharma Gets Registration Certificate for Moxifloxacin Hydrochloride Tablets	23-05-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ningbo Menovo Pharmaceutical Co., Ltd.

Equities

603538

CNE100002Y25

Summary

Filters